Plozalizumab (Anti-CCR2 / CD192)
Plozalizumab (Anti-CCR2 / CD192) is a specific humanized monoclonal antibody targeting CCR2. Plozalizumab can be used for malignant melanoma research. MW:145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2569 |
Sku # | A2569-1mg*5 |
Pricing | 1mg*5, $1690.00 |